Brigatinib Nitroso Impurity 2
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Brigatinib is used to treat a certain type of non-small cell lung cancer (NSCLC) that has spread to other parts of the bodys. Brigatinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply.Brigatinib Nitroso Impurity 2is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Brigatinib Nitroso Impurity 2 CAS NO:NA chemically represented as N-(5-Chloro-2-((2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)pyrimidin-4-yl)-N-(2-(dimethylphosphoryl) phenyl)nitrous amide . Synchemia is the leading manufacturing and exporter of Brigatinib Nitroso Impurity 2 . We supply Brigatinib Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N014469 |
| CAS No | NA |
| Mol.F. | C28H35ClN6O4S |
| Mol.Wt. | 587.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014470 |
| CAS No | NA |
| Mol.F. | C28H34ClN7O5S |
| Mol.Wt. | 616.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014471 |
| CAS No | NA |
| Mol.F. | C28H34ClN7O5S |
| Mol.Wt. | 616.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014472 |
| CAS No | NA |
| Mol.F. | C27H27N3O8 |
| Mol.Wt. | 521.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014473 |
| CAS No | NA |
| Mol.F. | C18H25ClN4O |
| Mol.Wt. | 348.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014474 |
| CAS No | 1053740-92-3 |
| Mol.F. | C22H30N4O6 |
| Mol.Wt. | 446.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014475 |
| CAS No | NA |
| Mol.F. | C28H35ClN6O4S |
| Mol.Wt. | 587.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014476 |
| CAS No | NA |
| Mol.F. | C13H10ClN3O3 |
| Mol.Wt. | 291.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014477 |
| CAS No | NA |
| Mol.F. | C21H22Cl2N2O7 |
| Mol.Wt. | 485.31 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014478 |
| CAS No | NA |
| Mol.F. | C26H26N2O5 |
| Mol.Wt. | 446.5 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N014479 |
| CAS No | NA |
| Mol.F. | C21H20F3IN4O3 |
| Mol.Wt. | 560.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014480 |
| CAS No | NA |
| Mol.F. | C21H20F3IN4O3 |
| Mol.Wt. | 560.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014481 |
| CAS No | NA |
| Mol.F. | C21H19F3IN5O4 |
| Mol.Wt. | 589.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014482 |
| CAS No | NA |
| Mol.F. | C21H21Cl2FN6O2 |
| Mol.Wt. | 479.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014483 |
| CAS No | NA |
| Mol.F. | C40H49N9O7 |
| Mol.Wt. | 767.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014484 |
| CAS No | NA |
| Mol.F. | C40H48N10O8 |
| Mol.Wt. | 796.9 |
| INV STATUS | CUSTOM SYNTHESIS |